Provider Reportable Diseases

Provider Reportable Diseases

Category 1 Disease Reporting

1. Report to DPH by phone on the day of diagnosis or suspicion.

Business hours: (860) 509-7994 Evenings, weekends, holidays: (860) 509-8000

2. Complete and submit a PD-23 within 12 hours.

3. Report to the local Director of Health in town of patient residence.

4. Diseases with specialized reporting forms are asterisked (*).

Category 1 Diseases

Acute HIV Infection	Poliomyelitis
Anthrax	Q fever
Botulism	Rabies
Brucellosis	Ricin poisoning
Cholera	Severe Acute Respiratory Syndrome (SARS)
Diphtheria	Smallpox
Measles	Staphylococcal enterotoxin B pulmonary poisoning
Melioidosis	Staphylococcus aureus disease, reduced or resistant susceptibility to vancomycin
Meningococcal disease	Syphilis, congenital
Outbreaks	Tuberculosis
◦ foodborne (involving ≥ 2 persons)	Tularemia
◦ institutional	Venezuelan equine encephalitis virus infection
◦ unusual disease or illness	Viral hemorrhagic fever
Plague	Yellow fever

Category 2 Disease Reporting

1. Complete and submit a PD-23 within 12 hours.

2. Hospital IPs entering cases in CTEDSS satisfies the reporting requirement.

3. Diseases with specialized reporting forms are asterisked (*).

Category 2 Diseases

Acquired Immunodeficiency Syndrome	Histoplasmosis
Acute flaccid myelitis	HIV-1/HIV-2 infection
Anaplasmosis	HPV: biopsy proven CIN 2, CIN 3, or AIS or their equivalent
Babesiosis	Influenza-associated death
Blastomycosis	Influenza-associated hospitalization
Blood lead ≥ 3.5μg/dL in pregnant persons	Legionellosis
Borrelia miyamotoi disease	Listeriosis
California group arbovirus infection	Malaria
Campylobacteriosis	Mercury poisoning
Candida auris	Mpox
Chancroid	Multisystem inflammatory syndrome in children (MIS-C)
Chickenpox (Varicella)	Mumps
Chickenpox-related death	Neonatal bacterial sepsis
Chikungunya	Occupational asthma
Chlamydia (C. trachomatis) (all sites)	Oropouche virus infection
COVID-19 death	Pertussis
COVID-19 hospitalization	Pneumococcal disease, invasive
Cronobacter in infants (<1 year)	Powassan virus infection
Cryptosporidiosis	Respiratory Syncytial Virus (RSV) associated death
Cyclosporiasis	RSV-associated hospitalization
Dengue	Rubella (including congenital)
E-cigarette or vaping product use associated lung injury (EVALI)	Salmonellosis
Eastern equine encephalitis virus infection	Shiga toxin-related diseases (gasteroenteritis)
Ehrlichia chaffeensis infection	Shigellosis
Escherichia coli O157:H7 infection	Silicosis
Escherichia coli, invasive, in infants (<1 year)	Spotted fever rickettsiosis
Gonorrhea*	St. Louis encephalitis virus infection
Group A Streptococcal disease, invasive	Syphilis*
Group B Streptococcal disease, invasive	Tetanus
Haemophilus influenzae disease, invasive	Trichinosis
Hansen’s disease (Leprosy)	Typhoid fever
Healthcare-associated infections	Vaccinia disease
Hemolytic-uremic syndrome	Vibrio infection (V. parahaemolyticus, V. vulnificus, others)
Hepatitis A	West Nile virus infection
Hepatitis B	Zika virus infection
◦ acute infection
◦ HBsAg positive pregnant women
Hepatitis C
◦ acute infection
◦ perinatal infection
◦ positive rapid antibody test result

PD-23 Footnotes

Report only to DPH.
As described in the CDC case definition.
Individual cases of “signicant unusual illness” are also reportable.
Fax PD-23 to (959) 200-4751.
Invasive disease: from sterile fluid (blood, CSF, pericardial, pleural, peritoneal, joint, or vitreous), bone, internal body sites, or other normally sterile site, including muscle.
Report Healthcare Associated Infections (HAIs) as required by Conn. Gen. Stat. §§ 19a-490o and 19a-215. Detailed instructions on the types of HAIs, facility types, locations and methods of reporting are available on the DPH website.
On request from the DPH and if adequate serum is available, send serum from patients with HUS to the State Public Health Laboratory for antibody testing.
Clinical sepsis and blood or CSF isolate obtained from an infant <3 days of age.